Inhibrx Biosciences, Inc. (INBX)
NASDAQ · Healthcare
Inhibrx Biosciences, Inc. Cash on Hand 2023–2025
Inhibrx Biosciences, Inc. annual/quarterly cash on hand history from 2023 to 2025. Cash on hand refers to the total amount of cash and cash equivalents held by a company.
- Inhibrx Biosciences, Inc. cash on hand for the quarter ending December 31, 2025 were 124.2M, a 18.60% decrease year-over-year.
- Inhibrx Biosciences, Inc. cash on hand for 2025 were 124.2M, a 18.60% decrease from 2024.
- Inhibrx Biosciences, Inc. cash on hand for 2024 were 152.6M, a 45.09% decrease from 2023.
- Inhibrx Biosciences, Inc. cash on hand for 2023 were 277.9M.
Cash on Hand
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Inhibrx Biosciences, Inc. Annual Cash on Hand (Millions of US $) | |
|---|---|
| 2025 | $124 |
| 2024 | $153 |
| 2023 | $278 |
| Inhibrx Biosciences, Inc. Quarterly Cash on Hand (Millions of US $) | |
|---|---|
| 2025-12-31 | $124 |
| 2024-12-31 | $153 |
| 2023-12-31 | $278 |
Inhibrx Biosciences, Inc. Cash on Hand — FAQ
Inhibrx Biosciences, Inc. (INBX) cash on hand over the last 3 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see INBX's cash on hand history?
The chart and table above show Inhibrx Biosciences, Inc.'s cash on hand by year and by quarter, including the growth rate.